Tech Company Financing Transactions

ClearNote Health Funding Round

ClearNote Health, based in San Diego, raised $52 million from private investors.

Transaction Overview

Company Name
Announced On
5/27/2026
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series D
Investors

private investors (Lead Investor) (Mattias Westman)

private investors (Sandy Weill)

private investors (Stephen Quake)

Proceeds Purpose
The company intends to use the funds to support continued commercial expansion, operational scale-up, clinical study execution, and product development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10578 Science Center Drive 210
San Diego, CA 92121
USA
Phone
Undisclosed
Email Address
Overview
ClearNote Health is a cancer detection company committed to extending and improving the lives of individuals at risk for high-mortality cancer. Using a standard blood draw, our proprietary 5hmC-epigenomic platform integrates advanced biology with artificial intelligence to deliver a more comprehensive view of molecular changes in the body, identifying DNA-based alterations as cancer develops.
Profile
ClearNote Health LinkedIn Company Profile
Social Media
ClearNote Health Company Twitter Account
Company News
ClearNote Health News
Facebook
ClearNote Health on Facebook
YouTube
ClearNote Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dave Mullarkey
  Dave Mullarkey LinkedIn Profile  Dave Mullarkey Twitter Account  Dave Mullarkey News  Dave Mullarkey on Facebook
Chief Marketing Officer
Jeremiah Bennett
  Jeremiah Bennett LinkedIn Profile  Jeremiah Bennett Twitter Account  Jeremiah Bennett News  Jeremiah Bennett on Facebook
Chief Medical Officer
Jeffrey Venstrom
  Jeffrey Venstrom LinkedIn Profile  Jeffrey Venstrom Twitter Account  Jeffrey Venstrom News  Jeffrey Venstrom on Facebook
Chief Scientific Officer
Samuel Levy
  Samuel Levy LinkedIn Profile  Samuel Levy Twitter Account  Samuel Levy News  Samuel Levy on Facebook
President
Kevin Kevin Keegan
  Kevin Kevin Keegan LinkedIn Profile  Kevin Kevin Keegan Twitter Account  Kevin Kevin Keegan News  Kevin Kevin Keegan on Facebook
Vice President
Daniel Black
  Daniel Black LinkedIn Profile  Daniel Black Twitter Account  Daniel Black News  Daniel Black on Facebook
Vice President
Eric Nilson
  Eric Nilson LinkedIn Profile  Eric Nilson Twitter Account  Eric Nilson News  Eric Nilson on Facebook
Vice President
Wayne Volkmuth
  Wayne Volkmuth LinkedIn Profile  Wayne Volkmuth Twitter Account  Wayne Volkmuth News  Wayne Volkmuth on Facebook
VP - Operations
Shimul Chowdhury
  Shimul Chowdhury LinkedIn Profile  Shimul Chowdhury Twitter Account  Shimul Chowdhury News  Shimul Chowdhury on Facebook
VP - Product Management
Anna Bergamaschi
  Anna Bergamaschi LinkedIn Profile  Anna Bergamaschi Twitter Account  Anna Bergamaschi News  Anna Bergamaschi on Facebook
VP - R & D
Gulfem Guler
  Gulfem Guler LinkedIn Profile  Gulfem Guler Twitter Account  Gulfem Guler News  Gulfem Guler on Facebook
VP - Regulatory Affairs
Irene Hsieh
  Irene Hsieh LinkedIn Profile  Irene Hsieh Twitter Account  Irene Hsieh News  Irene Hsieh on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/27/2026: Signos venture capital transaction
Next: 5/27/2026: C2i Semiconductors venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary